Francesca Barone

Francesca Barone is a declared insider of Candel Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 28 November 2022 and 29 June 2026, the trades on record add up to 13 filings.

Market trades split into 1 purchase (€1,896) and 7 sales (€916k). On balance, insiders were net sellers of €914k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 1 option exercise. 2026 to date brings no purchases and 1 sale.

The record was last updated on 1 July 2026 with an open-market sale (€206k) in Candel Therapeutics, Inc. The most recent open-market purchase was published on 12 December 2022, 1,412 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.